evidencegaps
Primary study · included by 1 review

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy.

Suss 2017 · Súss Shirlei Kugler Aiçar, Mesa Cleo Otaviano, Carvalho Gisah Amaral de, et al. · Archives of endocrinology and metabolism · 2018

Included by

Reassessing Radioactive Iodine Use After Thyroidectomy in Low-Risk Differentiated Thyroid Cancer: A Systematic Review and Meta-Analysis.
Non-Cochrane · intervention · 2026 · cited as Súss 2017 · Table 1; Fig. 3-8
Outcome this study informsPooled effectEvidenceCertainty
Recurrence
Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)
OR 0.66 [0.41, 1.08]7 studies · 4101 participantsGRADE not reported
Indeterminate response to treatment
Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)
OR 0.91 [0.46, 1.80]3 studies · 1104 participantsGRADE not reported
Structurally incomplete response to treatment
Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)
OR 1.49 [0.51, 4.36]3 studies · 1104 participantsGRADE not reported
Excellent response to treatment
Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)
OR 1.00 [0.52, 1.92]3 studies · 1104 participantsGRADE not reported
Biochemically incomplete response to treatment
Radioactive iodine (RAI) ablation after total thyroidectomy vs No RAI (total thyroidectomy alone)
OR 0.54 [0.10, 2.86]3 studies · 1104 participantsGRADE not reported

1 including review in total.